Dosing inconsistency further more contributes to variability in research outcomes. Cannabinoid dosages and dosing intervals will not be standardized across trials, with scientific studies utilizing a wide range of doses from low microgram concentrations to superior milligram regimens. Additionally, the titration methods used in clinical trials fluc